09 January 2002
Soluble cytokine receptors in renal vasculitis and lupus nephritis.
Vladimír Tesar, Milan Jirsa, Tomás Zima, Marta Kalousová, Jirina Bartunková, Alena Stejskalová, Ctibor Dostál, Jiri ZabkaMed Sci Monit 2002; 8(1): BR24-29 :: ID: 420974
Abstract
BACKGROUND: The activation of various cytokines, e.g. TNFalpha, IL-1 and/orIL-6, may play an important role in the pathogenesis of renal vasculitis and lupus nephritis (LN). Thesystemic effect of these cytokines may be modulated by their circulating soluble receptors. The plasmalevels of cytokine receptors may thus also be markers of the activation of these cytokines. MATERIAL/METHODS:The plasma levels of TNFalpha, its soluble receptor p75 (sTNF-RII), IL-6, and the soluble IL-6 receptor(sIL-6R) were measured using ELISA in 17 patients with ANCA-positive renal vasculitis (12 active - ANCA-A,7 in remission ANCA-R), 9 patients with active lupus nephritis (LN), and 5 healthy subjects. RESULTS:Patients with LN had increased plasma levels of TNFalpha, sTNF-RII, IL-6 and sIL-6R in comparison withcontrols. Patients with ANCA-A also had increased plasma levels of TNFalpha, sTNF-RII and sIL-6R in comparisonwith controls, but the increase in the plasma level of IL-6 was not statistically significant, due tothe large standard deviation. Patients with ANCA-R had increased plasma levels of sTNF-RII in comparisonto controls, but the plasma levels of TNFalpha were significantly lower in ANCA-R than in ANCA-A. Whilethe ratio of TNFalpha to sTNF-RII was significantly lower in all groups of patients than in the controls,the ratio of IL-6 to sIL-6R was significantly increased only in LN in comparison to controls. CONCLUSIONS:While increased plasma levels of TNFalpha may be a nonspecific marker of the activity of ANCA-positiverenal vasculitis and LN, plasma levels of sTNF-RII are also increased in patients with ANCA-positiverenal vasculitis in remission. Increased plasma levels of sTNF-RII may inhibit the systemic effects ofTNFalpha, but may also prolong the half-life of its active form. Plasma levels of sIL-6R are increasedboth in ANCA-A and in LN, but their increase is much less pronounced than that of sTNF-RII and cannoteffectively block the systemic effects of IL-6.
Keywords: Antigens, CD, Enzyme-Linked Immunosorbent Assay, Interleukin-6, Kidney Diseases, lupus nephritis, Receptors, Cytokine, Receptors, Interleukin-6, Receptors, Tumor Necrosis Factor, Receptors, Tumor Necrosis Factor, Type II, Research Support, Non-U.S. Gov, Vasculitis
840 6
Editorial
01 December 2023 : Editorial
Editorial: Outbreaks of Post-Pandemic Childhood Pneumonia and the Re-Emergence of Endemic Respiratory InfectionsDOI: 10.12659/MSM.943312
Med Sci Monit 2023; 29:e943312
In Press
04 Dec 2023 : Animal Research
Effects of Intrathecal Ketamine on Cerebrospinal Fluid Levels of Brain-Derived Neurotrophic Factor and Mech...Med Sci Monit In Press; DOI:
01 Dec 2023 : Clinical Research
Risk Factors and Clinical Outcomes of COVID-19 Infection in Multiple Sclerosis Patients: A Retrospective St...Med Sci Monit In Press; DOI:
30 Nov 2023 : Review article
Decoding the Neurological Sequelae of General Anesthesia: A ReviewMed Sci Monit In Press; DOI:
30 Nov 2023 : Clinical Research
Enhanced Pain Relief and Muscle Growth in Individuals with Low Back Instability: The Impact of Blood Flow R...Med Sci Monit In Press; DOI:
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292